Dr. Cornelius Liedtke - Net Worth and Insider Trading
Dr. Cornelius Liedtke Net Worth
The estimated net worth of Dr. Cornelius Liedtke is at least $0 dollars as of 2025-05-22. Dr. Cornelius Liedtke is the Supervisory Board of Encavis AG and owns about 0 shares of Encavis AG (XTER:ECV) stock worth over $0. Details can be seen in Dr. Cornelius Liedtke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Cornelius Liedtke has not made any transactions after 2021-04-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dr. Cornelius Liedtke
Dr. Cornelius Liedtke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dr. Cornelius Liedtke owns 1 companies in total, including Encavis AG (XTER:ECV) .
Click here to see the complete history of Dr. Cornelius Liedtke’s form 4 insider trades.
Insider Ownership Summary of Dr. Cornelius Liedtke
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
XTER:ECV | Encavis AG | 2021-04-21 | Supervisory Board |
Dr. Cornelius Liedtke Latest Holdings Summary
Dr. Cornelius Liedtke currently owns a total of 1 stock. Dr. Cornelius Liedtke owns 0 shares of Encavis AG (XTER:ECV) as of April 21, 2021, with a value of $0.
Latest Holdings of Dr. Cornelius Liedtke
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XTER:ECV | Encavis AG | 2021-04-21 | 0 | 17.53 | 0 |
Holding Weightings of Dr. Cornelius Liedtke
Dr. Cornelius Liedtke Form 4 Trading Tracker
According to the SEC Form 4 filings, Dr. Cornelius Liedtke has made a total of 2 transactions in Encavis AG (XTER:ECV) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Encavis AG is the acquisition of 170,100 shares on April 21, 2021, which cost Dr. Cornelius Liedtke around $3 Million.
Insider Trading History of Dr. Cornelius Liedtke
- 1
Dr. Cornelius Liedtke Trading Performance
GuruFocus tracks the stock performance after each of Dr. Cornelius Liedtke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Cornelius Liedtke is -3.75%. GuruFocus also compares Dr. Cornelius Liedtke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Cornelius Liedtke within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dr. Cornelius Liedtke's insider trading performs compared to the benchmark.
Performance of Dr. Cornelius Liedtke
Dr. Cornelius Liedtke Ownership Network
Ownership Network List of Dr. Cornelius Liedtke
Ownership Network Relation of Dr. Cornelius Liedtke

Dr. Cornelius Liedtke Owned Company Details
What does Encavis AG do?
Who are the key executives at Encavis AG?
Dr. Cornelius Liedtke is the Supervisory Board of Encavis AG. Other key executives at Encavis AG include Supervisory Board Albert Büll , Supervisory Board Dr. Henning Kreke , and Board of Directors Dr. Christoph Husmann .
Encavis AG (XTER:ECV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Encavis AG (XTER:ECV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Encavis AG (XTER:ECV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Encavis AG (XTER:ECV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Encavis AG Insider Transactions
Dr. Cornelius Liedtke Mailing Address
Above is the net worth, insider trading, and ownership report for Dr. Cornelius Liedtke. Currently GuruFocus does not have mailing address information for Dr. Cornelius Liedtke.